APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alzheimer's Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alzheimer's Drugs Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchAlzheimer's Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Alzheimer's Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Alzheimer's Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alzheimer's Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Alzheimer's Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alzheimer's Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alzheimer's Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alzheimer's Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alzheimer's Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alzheimer's Drugs include Johnson & Johnson, Novartis, Pfizer, Amgen, Eisai Pharmaceuticals, Biogen and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alzheimer's Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alzheimer's Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alzheimer's Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alzheimer's Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alzheimer's Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alzheimer's Drugs Market by Company

Johnson & Johnson

Novartis

Pfizer

Amgen

Eisai Pharmaceuticals

Biogen

Allergan

Alzheimer's Drugs Segment by Type

Acetylcholinesterase (AChE) Inhibitors

Glutamate Inhibitors

Other

Alzheimer's Drugs Segment by Application

Under 65 Years Old

65 and Above 65 Years Old

Alzheimer's Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer's Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alzheimer's Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer's Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alzheimer's Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alzheimer's Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Acetylcholinesterase (AChE) Inhibitors Table 2. Major Company of Glutamate Inhibitors Table 3. Major Company of Other Table 4. Global Alzheimer's Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 6. Global Alzheimer's Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Alzheimer's Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Alzheimer's Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Alzheimer's Drugs Sales by Type (2027-2032) & (W Units) Table 11. Global Alzheimer's Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Alzheimer's Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Alzheimer's Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Alzheimer's Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 16. North America Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 18. Europe Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 22. Latin America Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Alzheimer's Drugs Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Alzheimer's Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Alzheimer's Drugs Industry Trends Table 26. Alzheimer's Drugs Industry Drivers Table 27. Alzheimer's Drugs Industry Opportunities and Challenges Table 28. Alzheimer's Drugs Industry Restraints Table 29. Global Alzheimer's Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Alzheimer's Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Alzheimer's Drugs Sales by Company (2021-2026) & (W Units) Table 32. Global Alzheimer's Drugs Sales Share by Company (2021-2026) Table 33. Global Alzheimer's Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Alzheimer's Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Alzheimer's Drugs Major Company Production Sites and Headquarters Table 36. Global Alzheimer's Drugs Company, Product Type & Application Table 37. Global Alzheimer's Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Alzheimer's Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Alzheimer's Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Alzheimer's Drugs Sales by Region (2021-2026) & (W Units) Table 42. Global Alzheimer's Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Alzheimer's Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Alzheimer's Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Alzheimer's Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Alzheimer's Drugs Sales by Region (2027-2032) & (W Units) Table 47. Global Alzheimer's Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Alzheimer's Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Alzheimer's Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Alzheimer's Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Alzheimer's Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 53. Global Alzheimer's Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Alzheimer's Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Alzheimer's Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Alzheimer's Drugs Sales by Application (2027-2032) & (W Units) Table 58. Global Alzheimer's Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Alzheimer's Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Alzheimer's Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Alzheimer's Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 63. North America Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 65. Europe Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 69. Latin America Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Alzheimer's Drugs Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Alzheimer's Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Alzheimer's Drugs Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis Alzheimer's Drugs Product Portfolio Table 81. Novartis Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Alzheimer's Drugs Product Portfolio Table 86. Pfizer Recent Development Table 87. Amgen Company Information Table 88. Amgen Business Overview Table 89. Amgen Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Amgen Alzheimer's Drugs Product Portfolio Table 91. Amgen Recent Development Table 92. Eisai Pharmaceuticals Company Information Table 93. Eisai Pharmaceuticals Business Overview Table 94. Eisai Pharmaceuticals Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Eisai Pharmaceuticals Alzheimer's Drugs Product Portfolio Table 96. Eisai Pharmaceuticals Recent Development Table 97. Biogen Company Information Table 98. Biogen Business Overview Table 99. Biogen Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Biogen Alzheimer's Drugs Product Portfolio Table 101. Biogen Recent Development Table 102. Allergan Company Information Table 103. Allergan Business Overview Table 104. Allergan Alzheimer's Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Allergan Alzheimer's Drugs Product Portfolio Table 106. Allergan Recent Development Table 107. North America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 108. North America Alzheimer's Drugs Sales by Country (2021-2026) & (W Units) Table 109. North America Alzheimer's Drugs Sales Market Share by Country (2021-2026) Table 110. North America Alzheimer's Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 111. North America Alzheimer's Drugs Sales Market Share Forecast by Country (2027-2032) Table 112. North America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Alzheimer's Drugs Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Alzheimer's Drugs Market Share by Country (2021-2026) Table 115. North America Alzheimer's Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Alzheimer's Drugs Market Share Forecast by Country (2027-2032) Table 117. Europe Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 118. Europe Alzheimer's Drugs Sales by Country (2021-2026) & (W Units) Table 119. Europe Alzheimer's Drugs Sales Market Share by Country (2021-2026) Table 120. Europe Alzheimer's Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 121. Europe Alzheimer's Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Alzheimer's Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Alzheimer's Drugs Market Share by Country (2021-2026) Table 125. Europe Alzheimer's Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Alzheimer's Drugs Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Alzheimer's Drugs Sales by Country (2021-2026) & (W Units) Table 129. Asia-Pacific Alzheimer's Drugs Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Alzheimer's Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 131. Asia-Pacific Alzheimer's Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Alzheimer's Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Alzheimer's Drugs Market Share by Country (2021-2026) Table 135. Asia-Pacific Alzheimer's Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Alzheimer's Drugs Market Share Forecast by Country (2027-2032) Table 137. Latin America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 138. Latin America Alzheimer's Drugs Sales by Country (2021-2026) & (W Units) Table 139. Latin America Alzheimer's Drugs Sales Market Share by Country (2021-2026) Table 140. Latin America Alzheimer's Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 141. Latin America Alzheimer's Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Alzheimer's Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Alzheimer's Drugs Market Share by Country (2021-2026) Table 145. Latin America Alzheimer's Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Alzheimer's Drugs Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Alzheimer's Drugs Sales by Country (2021-2026) & (W Units) Table 149. Middle East and Africa Alzheimer's Drugs Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Alzheimer's Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 151. Middle East and Africa Alzheimer's Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Alzheimer's Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Alzheimer's Drugs Market Share by Country (2021-2026) Table 155. Middle East and Africa Alzheimer's Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Alzheimer's Drugs Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Alzheimer's Drugs Distributors List Table 160. Alzheimer's Drugs Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Alzheimer's Drugs Image Figure 2. Global Alzheimer's Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alzheimer's Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Alzheimer's Drugs Sales (2021-2032) & (W Units) Figure 5. Acetylcholinesterase (AChE) Inhibitors Image Figure 6. Global Acetylcholinesterase (AChE) Inhibitors Sales YoY Growth (2021-2032) & (W Units) Figure 7. Glutamate Inhibitors Image Figure 8. Global Glutamate Inhibitors Sales YoY Growth (2021-2032) & (W Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Alzheimer's Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Alzheimer's Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Alzheimer's Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Alzheimer's Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Alzheimer's Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Alzheimer's Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Alzheimer's Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Alzheimer's Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Alzheimer's Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Alzheimer's Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Alzheimer's Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Alzheimer's Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Alzheimer's Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Under 65 Years Old Image Figure 26. Global Under 65 Years Old Sales YoY Growth (2021-2032) & (W Units) Figure 27. 65 and Above 65 Years Old Image Figure 28. Global 65 and Above 65 Years Old Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Alzheimer's Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Alzheimer's Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Alzheimer's Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Alzheimer's Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Alzheimer's Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Alzheimer's Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Alzheimer's Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Alzheimer's Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Alzheimer's Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Alzheimer's Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Alzheimer's Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Alzheimer's Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Alzheimer's Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Alzheimer's Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Alzheimer's Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Alzheimer's Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alzheimer's Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Alzheimer's Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Alzheimer's Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Alzheimer's Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alzheimer's Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Alzheimer's Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Alzheimer's Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Alzheimer's Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alzheimer's Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Alzheimer's Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Alzheimer's Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Alzheimer's Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alzheimer's Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Alzheimer's Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Alzheimer's Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Alzheimer's Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Alzheimer's Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Alzheimer's Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Acetylcholinesterase (AChE) Inhibitors
  • Glutamate Inhibitors
  • Other
Applications
  • Under 65 Years Old
  • 65 and Above 65 Years Old
Companies covered
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Amgen
  • Eisai Pharmaceuticals
  • Biogen
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alzheimer's Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alzheimer's Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alzheimer's Drugs Market by Type
  6. 1.3.1 Acetylcholinesterase (AChE) Inhibitors
  7. 1.3.2 Glutamate Inhibitors
  8. 1.3.3 Other
  9. 1.4 Global Alzheimer's Drugs Market Size by Type
  10. 1.4.1 Global Alzheimer's Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Alzheimer's Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Alzheimer's Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Alzheimer's Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Alzheimer's Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Alzheimer's Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Alzheimer's Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Alzheimer's Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alzheimer's Drugs Industry Trends
  2. 2.2 Alzheimer's Drugs Industry Drivers
  3. 2.3 Alzheimer's Drugs Industry Opportunities and Challenges
  4. 2.4 Alzheimer's Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alzheimer's Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Alzheimer's Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Alzheimer's Drugs Price (2021-2026)
  4. 3.4 Global Alzheimer's Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alzheimer's Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Alzheimer's Drugs Company, Product Type & Application
  7. 3.7 Global Alzheimer's Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alzheimer's Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alzheimer's Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alzheimer's Drugs Tier 1, Tier 2, and Tier 3
4 Alzheimer's Drugs Regional Status and Outlook
  1. 4.1 Global Alzheimer's Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alzheimer's Drugs Historic Market Size by Region
  3. 4.2.1 Global Alzheimer's Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alzheimer's Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alzheimer's Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alzheimer's Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Alzheimer's Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alzheimer's Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alzheimer's Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alzheimer's Drugs by Application
  1. 5.1 Alzheimer's Drugs Market by Application
  2. 5.1.1 Under 65 Years Old
  3. 5.1.2 65 and Above 65 Years Old
  4. 5.2 Global Alzheimer's Drugs Market Size by Application
  5. 5.2.1 Global Alzheimer's Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alzheimer's Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alzheimer's Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alzheimer's Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alzheimer's Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alzheimer's Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alzheimer's Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alzheimer's Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Alzheimer's Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Alzheimer's Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Alzheimer's Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Amgen
  20. 6.4.1 Amgen Company Information
  21. 6.4.2 Amgen Business Overview
  22. 6.4.3 Amgen Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Alzheimer's Drugs Product Portfolio
  24. 6.4.5 Amgen Recent Developments
  25. 6.5 Eisai Pharmaceuticals
  26. 6.5.1 Eisai Pharmaceuticals Company Information
  27. 6.5.2 Eisai Pharmaceuticals Business Overview
  28. 6.5.3 Eisai Pharmaceuticals Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eisai Pharmaceuticals Alzheimer's Drugs Product Portfolio
  30. 6.5.5 Eisai Pharmaceuticals Recent Developments
  31. 6.6 Biogen
  32. 6.6.1 Biogen Company Information
  33. 6.6.2 Biogen Business Overview
  34. 6.6.3 Biogen Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biogen Alzheimer's Drugs Product Portfolio
  36. 6.6.5 Biogen Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Alzheimer's Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Alzheimer's Drugs Product Portfolio
  42. 6.7.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Alzheimer's Drugs Sales by Country
  2. 7.1.1 North America Alzheimer's Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alzheimer's Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Alzheimer's Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alzheimer's Drugs Market Size by Country
  6. 7.2.1 North America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alzheimer's Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Alzheimer's Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alzheimer's Drugs Sales by Country
  2. 8.1.1 Europe Alzheimer's Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alzheimer's Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Alzheimer's Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alzheimer's Drugs Market Size by Country
  6. 8.2.1 Europe Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alzheimer's Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alzheimer's Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alzheimer's Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Alzheimer's Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alzheimer's Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alzheimer's Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alzheimer's Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alzheimer's Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alzheimer's Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alzheimer's Drugs Sales by Country
  2. 10.1.1 South America Alzheimer's Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alzheimer's Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Alzheimer's Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alzheimer's Drugs Market Size by Country
  6. 10.2.1 South America Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alzheimer's Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Alzheimer's Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alzheimer's Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Alzheimer's Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alzheimer's Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alzheimer's Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alzheimer's Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Alzheimer's Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alzheimer's Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alzheimer's Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alzheimer's Drugs Value Chain Analysis
  2. 12.1.1 Alzheimer's Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alzheimer's Drugs Production Mode & Process
  7. 12.2 Alzheimer's Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alzheimer's Drugs Distributors
  10. 12.2.3 Alzheimer's Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst